GlassScriptPhysician profile
Brendan Michael Lindsey
NPI 1457087496
$2,626.54
in general payments reported to CMS, 2019-2025
24 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $957 · 2024: $1,000 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $345.16 | 2022-2024 | Axonics |
| Janssen Biotech, INC. | $299.29 | 2022-2024 | Erleada |
| Sumitomo Pharma America, INC. | $255.69 | 2023-2025 | Gemtesa, Orgovyx |
| Progenics Pharmaceuticals, INC. | $241.98 | 2022-2025 | Pylarify |
| Astellas Pharma US INC | $160.60 | 2022-2025 | Myrbetriq, Xtandi |
| Pfizer INC. | $151.00 | 2023-2024 | |
| Procept Biorobotics Corporation | $140.65 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Coloplast Corp | $110.12 | 2023-2025 | Speedicath |
| Abbvie INC. | $104.34 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $93.19 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Antares Pharma, INC. | $88.00 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Hollister Incorporated | $85.25 | 2023-2024 | Infyna Chic, Vapro, Onli |
| Sage Therapeutics, LLC | $67.43 | 2023 | |
| Urogen Pharma, INC. | $65.92 | 2023-2024 | Jelmyto |
| Immunitybio, INC. | $62.67 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $59.21 | 2024 | |
| Accord Healthcare, INC. | $58.29 | 2023-2024 | |
| Blue Earth Diagnostics | $51.53 | 2022-2023 | |
| Tolmar, INC. | $50.54 | 2024-2025 | Jatenzo, Eligard |
| Endo Pharmaceuticals INC. | $38.24 | 2023-2024 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $30.60 | 2024 | |
| Ferring Pharmaceuticals INC. | $28.13 | 2024 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $21.70 | 2022 | |
| Teleflex LLC | $17.01 | 2024 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendan Lindsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.